Lucas Jane S A, Lewis Stella A, Trewin Jennifer B, Grimshaw Kate E C, Warner John O, Hourihane Jonathan O'B
Allergy and Inflammation Sciences, University of Southampton, Southampton, UK.
Pediatr Allergy Immunol. 2005 Dec;16(8):647-54. doi: 10.1111/j.1399-3038.2005.00330.x.
Actinidia chinensis (gold kiwi) is a newly available fruit which has been shown to have in vitro immunoglobulin E (IgE) cross-reactivity with green kiwi. This is the first study to investigate clinical reactivity of gold kiwi. Five patients clinically allergic to green kiwi were investigated by skin test and double-blind placebo controlled food challenge (DBPCFC) with gold kiwi fruit. IgE-binding patterns of individual sera from the five challenged patients and a pool of sera from a further nine patients with kiwi allergy were compared in the two fruits by Western blotting. Cross reactivity of proteins in the two fruits was assessed by inhibition of immunoblots and by IgE enzyme-linked immunosorbent assay (ELISA) inhibition. Four of the five patients had a positive DBPCFC to gold kiwi. Western blotting showed marked differences in the allergen patterns of green and gold kiwi. However, inhibition of the immunoblots and ELISA assay reveals extensive inhibition of IgE binding to proteins in each fruit by the alternative species. Gold kiwi fruit is allergenic and patients allergic to green kiwi are at risk of reacting to the gold kiwi fruit. Despite having different protein profiles and IgE-binding patterns, the two species have proteins that extensively cross-inhibit the binding to IgE.
中华猕猴桃(金奇异果)是一种新上市的水果,已被证明在体外与绿奇异果存在免疫球蛋白E(IgE)交叉反应性。这是第一项研究金奇异果临床反应性的研究。对五名临床上对绿奇异果过敏的患者进行了皮肤试验,并采用金奇异果进行双盲安慰剂对照食物激发试验(DBPCFC)。通过蛋白质印迹法比较了五名受试患者的个体血清以及另外九名奇异果过敏患者的混合血清在这两种水果中的IgE结合模式。通过免疫印迹抑制和IgE酶联免疫吸附测定(ELISA)抑制来评估两种水果中蛋白质的交叉反应性。五名患者中有四名对金奇异果的DBPCFC呈阳性。蛋白质印迹显示绿奇异果和金奇异果的过敏原模式存在显著差异。然而,免疫印迹抑制和ELISA测定表明,另一种水果中的蛋白质对每种水果中IgE与蛋白质的结合具有广泛的抑制作用。金奇异果具有致敏性,对绿奇异果过敏的患者有对金奇异果产生反应的风险。尽管两种水果的蛋白质谱和IgE结合模式不同,但它们具有能广泛交叉抑制与IgE结合的蛋白质。